Neulasta
FDA Delay Coherus’ Approvals for PD-1 Inhibitor and Neulasta Biosimilar Injector
Anika Sharma
Coherus BioSciences has experienced a challenging journey in seeking FDA approval for its PD-1 inhibitor, toripalimab, developed in partnership with ...
